Project Grant R01NS128285
Award Date
7/1/24
Completion Date
5/31/29
Dollars Obligated
$509K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, aims to investigate the impact of mutant ataxin 1 (mATXN1) on the function of cerebellar astrocytes and how astrocyte dysfunctions contribute to the onset and progression of Spinocerebellar Ataxia Type 1 (SCA1) disease. The award of $454,999.00 over the period of July 1,...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant of $423,500.00 to the Regents of the University of Minnesota under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The funding will support research to determine how the dysfunction of the cerebellar nuclei, a key part of the cerebellar network, contributes to the motor deficits associated with Spinocerebellar Ataxia Type 1 (SCA1), a...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the federal Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $233,280 to the Regents of the University of Michigan to conduct research on spinocerebellar ataxias (SCAs). The goal is to characterize the mechanisms by which circuit modulation and dendritic plasticity impact the progression of these neurodegenerative disorders, with...
This federal Project Grant award of $458,189, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the role of membrane-remodeling factors in regulating oligodendrocyte morphology and myelination in the central nervous system.
The key research objectives are to: (1) conduct expression profiling to identify membrane-remodeling...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $457,875.00 to the University of Connecticut Health Center to conduct research on the molecular heterogeneity and developmental mechanisms of the inferior olivary nucleus.
The key objectives of this 2-year project (7/5/2024 - 6/30/2026) are to construct a 3D molecular...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services, awarded a $4,528,840 Project Grant to The Salk Institute For Biological Studies under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The three-year award beginning August 19, 2022 will fund research to functionally dissect cerebellar output circuits that orchestrate limb motor control. Specifically, the grantee will...
This federal Project Grant award for $444,599.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research investigating the impact of neuronal activity on oligodendrocyte progenitor cell proliferation, survival, and differentiation. The primary awardee, the University of Colorado-Denver, will use designer receptor technology to manipulate...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $654,844 in funding to the University of Virginia to study the mechanisms underlying the pathogenesis of SEL1L-HRD1 ERAD disease variants. The primary objectives are to determine the causality and pathophysiological significance of human SEL1L and SYVN1 variants, and to...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), supports research to investigate the effects of re-expressing embryonic motor neuron selector transcription factors ISL1 and LHX3 in mouse models of amyotrophic lateral sclerosis (ALS) and in ALS patient-derived motor neurons. The key objectives are to examine how the re-expression of these factors impacts early and late ALS pathologies...
This $616,200 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853) will fund research to explore the role of neuromelanin accumulation in dopamine neurons and its effects on cellular physiology, neuroinflammation, and neurodegeneration in Parkinson's disease. The primary awardee, the Oklahoma Medical Research Foundation, will work...